These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 2686529)

  • 1. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive or inducible overexpression of the IGF-2 gene in cells of a human colon carcinoma cell line.
    Lamonerie T; Lavialle C; de Galle B; Binoux M; Brison O
    Exp Cell Res; 1995 Feb; 216(2):342-51. PubMed ID: 7531153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.
    Modjtahedi N; Lavialle C; Poupon MF; Landin RM; Cassingena R; Monier R; Brison O
    Cancer Res; 1985 Sep; 45(9):4372-9. PubMed ID: 4028021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
    Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
    Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.
    Donzelli M; Bernardi R; Negri C; Prosperi E; Padovan L; Lavialle C; Brison O; Scovassi AI
    Oncogene; 1999 Jan; 18(2):439-48. PubMed ID: 9927200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.
    Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A
    Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification.
    Martinsson T; Ståhl F; Pollwein P; Wenzel A; Levan A; Schwab M; Levan G
    Oncogene; 1988 Oct; 3(4):437-41. PubMed ID: 3078951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
    J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
    Brondyk WH; Boeckman FA; Fahl WE
    Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proto-oncogene FGF-3 is constitutively expressed in tumorigenic, but not in non-tumorigenic, clones of a human colon carcinoma cell line.
    Galdemard C; Brison O; Lavialle C
    Oncogene; 1995 Jun; 10(12):2331-42. PubMed ID: 7784081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
    Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
    Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
    Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
    Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of myc gene amplification in human somatic cell hybrids.
    Iman DS; Shay JW
    Cancer Res; 1989 Aug; 49(16):4417-22. PubMed ID: 2568170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
    Zajchowski D; Band V; Pauzie N; Tager A; Stampfer M; Sager R
    Cancer Res; 1988 Dec; 48(24 Pt 1):7041-7. PubMed ID: 3191480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
    Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
    Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
    Bover L; Barrio M; Bravo AI; Slavutsky I; Larripa I; Bolondi A; Ayala M; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):493-504. PubMed ID: 9620446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.